These observations suggested that gardenoside could mitigate several NAFLD-induced impairments and, most importantly, CTCF knockdown and DPP4 silencing generated results similar to that induced by gardenoside. The gene discussed is DPP4; the disease is metabolic dysfunction-associated steatotic liver disease.